Clinical trial
Stop Atherosclerosis in Native Diabetics Study
NCT00147251 · Cynthia West, Other · Completed
Key facts
| NCT number | NCT00147251 |
|---|---|
| Title | Stop Atherosclerosis in Native Diabetics Study |
| Official title | Stop Atherosclerosis in Native Diabetics Study |
| Acronym | SANDS |
| Lead sponsor | Cynthia West, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease, Hypertension, Hyperlipidemia, Diabetes, Carotid Atherosclerosis |
| Intervention type | Drug |
| Interventions | FDA approved drugs to treat blood pressure and cholesterol |
| Enrollment | 548 |
| Start date | May 1, 2003 |
| Primary completion | Nov 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Jul 7, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: